Evidence map›Paper›PMID 32245907›Full record

ArticleGut2021

Fibrosis-4 (FIB-4) score at the primary care level: an analysis of over 160 000 blood samples.

David Petroff, Olaf Bätz, Katrin Jedrysiak, Jan Kramer, Thomas Berg, Johannes Wiegand

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Gut, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Frontiers in medicine · 2021
    Article
  5. Article
  6. Observational
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

David PetroffClinical Trial Centre, Leipzig University, Leipzig, Sachsen, Germany.ORCID 0000-0002-6916-1465
Olaf BätzLADR Laboratory Group Dr Kramer & Colleagues, Geesthacht, Germany.
Katrin JedrysiakLADR Laboratory Group Dr Kramer & Colleagues, Geesthacht, Germany.
Jan KramerLADR Laboratory Group Dr Kramer & Colleagues, Geesthacht, Germany.
Thomas BergClinic of Oncology, Gastroenterology, Hepatology, Pneumology and Infectious Diseases, Leipzig University, Leipzig, Sachsen, Germany.
Johannes WiegandDepartment of Gastroenterology, Leipzig University, Leipzig, Sachsen, Germany Johannes.Wiegand@medizin.uni-leipzig.de.ORCID 0000-0001-9233-4064

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Non-alcoholic Fatty Liver DiseaseHumansLiver CirrhosisPrimary Health Carenonalcoholic steatohepatitisprimary carescreening

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.